Infinity Pharmaceuticals,Inc.,Anaheim,Calif.,has announced positive preclinical data on the company's novel investigational compound IPI-504,a potent inhibitor of Heat Shock Protein 90 (Hsp90).Results demonstrate that IPI-504 significantly reduces tumor burden in several animal models of cancer,...
Mr. Gal-Or continued, "Of equal importance is IPB's mandate to back Chinese companies seeking to upgrade and better compete in China as well as internationally. Our recent investments in China's THT (NASDAQ:THTI, “THT”) and Shijiazhuang Xingbai Pharmaceuticals are prime examples of IPB's...
The article reports that Infinity Pharmaceuticals Inc., a Cambridge, Massachusetts drug developer, is planning for the future, while many of its biotech peers are struggling to survive. The company is creating various treatments for cancer and has an aggressive growth plan that includes selling its...